Lange Allison, Lasser Karen E, Xuan Ziming, Khalid Laila, Beers Donna, Heymann Orlaith D, Shanahan Christopher W, Crosson Julie, Liebschutz Jane M
Department of General Internal Medicine, Boston Medical Center, Boston, MA, USA Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA Department of Adult Medicine, Dorchester House Community Health Center, Boston, MA, USA Department of Adult Medicine, Mattapan Community Health Center, Boston, MA, USA.
Pain. 2015 Feb;156(2):335-340. doi: 10.1097/01.j.pain.0000460314.73358.ff.
Little is known about variability in primary care providers' (PCPs) adherence to opioid-monitoring guidelines for patients. We examined variability of adherence to monitoring guidelines among PCPs and ascertained the relationship between PCP adherence and opioid misuse by their patients. We included primary care patients receiving long-term opioids (≥3 prescriptions within 6 months) for chronic noncancer pain and PCPs with ≥4 eligible patients. We examined guideline adherence using: (1) electronic health record documentation of opioid treatment agreement, (2) past-year urine drug screen (UDS), and (3) evidence of misuse through early refills (≥2 opioid prescriptions written 7-25 days after the previous prescription). Covariates included morphine equivalent daily opioid medication dose (MED, >50 mg/d vs ≤50mg/d). Multilevel regression models assessed variability among PCPs, and odds ratios examined associations among patient-level binary outcomes. Sixty-seven PCPs prescribed opioids to 1546 patients. Significant variability was found between PCPs in use of agreement (variance = 1.27, P < 0.001), UDS (variance = 1.75, P < 0.001), and early refills (variance = 0.29, P = 0.002). Primary care providers had a mean of 48% of patients with agreement (range, 9%-84%), 56% with ≥1 UDS (range, 7%-91%) and 36% with early refills (range, 19%-60%). High MED among patients was associated with increased odds of agreement (1.93, confidence interval [CI], 1.53-2.44), UDS (2.65, CI: 2.06-3.41), and early refill (2.92, CI: 2.30-3.70). Primary care providers varied significantly in adherence to opioid prescription guidelines. Increased patient risk was associated with increased monitoring and with greater misuse. Future work should study system-level interventions to enable clinical monitoring and support opioid guideline adherence.
关于初级保健提供者(PCP)对患者阿片类药物监测指南的依从性差异,目前所知甚少。我们研究了PCP对监测指南的依从性差异,并确定了PCP的依从性与其患者阿片类药物滥用之间的关系。我们纳入了因慢性非癌性疼痛接受长期阿片类药物治疗(6个月内≥3张处方)的初级保健患者以及拥有≥4名符合条件患者的PCP。我们使用以下方法检查指南依从性:(1)阿片类药物治疗协议的电子健康记录文档,(2)过去一年的尿液药物筛查(UDS),以及(3)通过提前 refill(在前一张处方开具后7 - 25天内开具≥2张阿片类药物处方)的滥用证据。协变量包括每日阿片类药物等效吗啡剂量(MED,>50 mg/d与≤50mg/d)。多水平回归模型评估了PCP之间的差异,比值比检验了患者水平二元结局之间的关联。67名PCP为1546名患者开具了阿片类药物。在PCP之间,协议使用情况(方差 = 1.27,P < 0.001)、UDS(方差 = 1.75,P < 0.001)和提前 refill(方差 = 0.29,P = 0.002)存在显著差异。初级保健提供者平均有48%的患者有协议(范围为9% - 8�%),56%的患者进行了≥1次UDS(范围为7% - 91%),36%的患者有提前 refill(范围为19% - 60%)。患者中高MED与协议达成几率增加(1.93,置信区间[CI],1.53 - 2.44)、UDS(2.65,CI:2.06 - 3.41)和提前 refill(2.92,CI:2.30 - 3.70)相关。初级保健提供者在阿片类药物处方指南的依从性方面存在显著差异。患者风险增加与监测增加以及更多滥用相关。未来的工作应研究系统层面的干预措施,以实现临床监测并支持阿片类药物指南的依从性。